Pfizer, BioNTech ask U.S. regulators to okay COVID-19 vaccine for kids
Updated 2021.10.07 20:53 GMT+8
CGTN
Pfizer Inc and BioNTech said on Thursday they had asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged from five to 11.